Janon, Sendoy .

HRN: 22-39-72  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/21/2025
07/28/2025
IV
525mg
Q6h
PCAP C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines